Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 8Unknown 3Active not recruiting 3Terminated 1

Sponsor Class

OTHER 31NIH 4NETWORK 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Other hematologic neoplasm 1Myeloid 1

Conditions

Gastrointestinal Stromal Tumors 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiotherapy, Intensity-Modulated 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Conformal 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × NETWORK × Imatinib Mesylate × Clear all
NCT02365441 2023-07-07

ALT GIST

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown
78 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04578847 2020-10-08

READIT

National Research Center for Hematology, Russia

Phase 2 Unknown
100 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00685828 2014-07-04

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
946 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡